VENTURE CAPITAL POST

For a Round-A venture capital investment, Vodafone Ventures Egypt would be taking a 22.22% stake in online pharmacy Agzakhana.com.

In a surprising but laudable move, multinational retail company Walmart released changes on its 2014 healthcare package, including a provision for LGBT employees to elect domestic spouses in health insurance.

Baird Capital recently announced its investment in China's Kedu Healthcare.

Five investment projects were approved by Malaysia's National Key Economic Area today.

Pharmaceuticals companies PharmAthene and Theraclone Sciences agreed to merge for expansion of drug research and development.

Venture capital fund Ascension Health Ventures backs healthcare technology innovator Quantros.

American hospital chain Community Health agreed to buy Health Management Associates Inc. for US$3.9 billion in cash and stock.

A report revealed that healthcare investments to Cleveland in the fist half of 2013 was US$80 million, down from the US$104 million in the same period last year.

JenaValve Technology secures US $62.5 million in series C financing, with investments coming from both new and existing investors.

Pharmaceutical giants Pfizer, AstraZeneca and Novartis are among those to propose bids for Onyx Pharmaceuticals.

Conatus Pharmaceuticals offered 5 million shares for another IPO.

Adcock Ingram Holdings Ltd. received a non-binding proposal from Chilean drug manufacturer CFR Pharmaceuticals SA for US$1.3 billion.

Fresenius sold its transplantation medicine and anti-cancer cell drug to Neopharm.

Complix completed its Series B funding as Edmond de Rothschild Investment Partners and GMIV handed their support.

Tenet Healthcare bought Vanguard Health Systems for $4.3 billion.